Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1

World Journal of Gastroenterology

Volumn 19, Issue 33, 2013, Pages 5500-5507

  Iraha, Atsushi ^a   Chinen, Hiroshi ^b   Hokama, Akira ^a   Yonashiro, Takumi ^c   Kinjo, Tetsu ^b   Kishimoto, Kazuto ^a   Nakamoto, Manabu ^b   Hirata, Tetsuo ^a   Kinjo, Nagisa ^b   Higa, Futoshi ^a   Tateyama, Masao ^a   Kinjo, Fukunori ^b   Fujita, Jiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^c Uruma Bio Co Ltd   (Japan)

Author keywords

Fucoidan; Inflammatory bowel diseases; Intestinal epithelial cells; Oxidative stress; Tight junction

Indexed keywords

CLAUDIN 1; CLAUDIN 2; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; FUCOIDIN; OCCLUDIN;

ARTICLE; CELL DAMAGE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE RESISTANCE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG MEGADOSE; ENTERITIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTESTINE FUNCTION; LOW DRUG DOSE; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

FUCOIDAN; INFLAMMATORY BOWEL DISEASES; INTESTINAL EPITHELIAL CELLS; OXIDATIVE STRESS; TIGHT JUNCTION;

ANTI-ULCER AGENTS; CACO-2 CELLS; CLAUDIN-1; DRUG EVALUATION, PRECLINICAL; EPITHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; POLYSACCHARIDES; TIGHT JUNCTIONS; UP-REGULATION;

EID: 84883508927     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i33.5500     Document Type: Article

References (36)

1. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434 [PMID: 17653185 DOI: 10.1038/nature06005]
2. Hibi T, Ogata H. Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 2006; 41: 10-16 [PMID: 16501852 DOI: 10.1007/s00535-005-1744-3]
3. Sartor RB. Mechanisms of disease: pathogenesis of Crohn' s disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2006; 3: 390-407 [PMID: 16819502 DOI: 10.1038/ncpgasthep0528]
4. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117: 514-521 [PMID: 17332878 DOI: 10.1172/JCI30587]
5. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8: 411-420 [PMID: 18469830 DOI: 10.1038/ nri2316]
6. Wehkamp J, Stange EF. Paneth cells and the innate immune response. Curr Opin Gastroenterol 2006; 22: 644-650 [PMID: 17053443]
7. Rimoldi M, Chieppa M, Salucci V, Avogadri F, Sonzogni A, Sampietro GM, Nespoli A, Viale G, Allavena P, Rescigno M. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 2005; 6: 507-514 [PMID: 15821737 DOI: 10.1038/ni1192]
8. Coombes JL, Powrie F. Dendritic cells in intestinal immune regulation. Nat Rev Immunol 2008; 8: 435-446 [PMID: 18500229 DOI: 10.1038/nri2335]
9. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol 2009; 9: 799-809 [PMID: 19855405 DOI: 10.1038/nri2653]
10. Hering NA, Fromm M, Schulzke JD. Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. J Physiol 2012; 590: 1035-1044 [PMID: 22219336 DOI: 10.1113/jphysiol.2011.224568]
11. Zhu H, Li YR. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med (Maywood) 2012; 237: 474-480 [PMID: 22442342 DOI: 10.1258/ebm.2011.011358]
12. Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989; 96: 736-749 [PMID: 2914637]
13. Wang N, Wang G, Hao J, Ma J, Wang Y, Jiang X, Jiang H. Curcumin ameliorates hydrogen peroxide-induced epithelial barrier disruption by upregulating heme oxygenase-1 expression in human intestinal epithelial cells. Dig Dis Sci 2012; 57: 1792-1801 [PMID: 22392462 DOI: 10.1007/ s10620-012-2094-7]
14. Fitton JH. Therapies from fucoidan; multifunctional marine polymers. Mar Drugs 2011; 9: 1731-1760 [PMID: 22072995 DOI: 10.3390/md9101731]
15. Ramberg JE, Nelson ED, Sinnott RA. Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr J 2010; 9: 54 [PMID: 21087484 DOI: 10.1186/1475-2891-9-54]
16. Holtkamp AD, Kelly S, Ulber R, Lang S. Fucoidans and fucoidanases--focus on techniques for molecular structure elucidation and modification of marine polysaccharides. Appl Microbiol Biotechnol 2009; 82: 1-11 [PMID: 19043701 DOI: 10.1007/s00253-008-1790-x]
17. Maher S, Feighery L, Brayden DJ, McClean S. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers. Pharm Res 2007; 24: 1336-1345 [PMID: 17373574 DOI: 10.1007/s11095-007-9288-2]
18. Wang HB, Wang PY, Wang X, Wan YL, Liu YC. Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription. Dig Dis Sci 2012; 57: 3126-3135 [PMID: 22684624 DOI: 10.1007/ s10620-012-2259-4]
19. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000; 118: 1001-1011 [PMID: 10833473 DOI: 10.1016/S0016-5085(00)70351-9]
20. Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 2003; 52: 439-451 [PMID: 12584232 DOI: 10.1136/gut.52.3.439]
21. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001; 159: 2001-2009 [PMID: 11733350 DOI: 10.1016/S0002-9440(10)63051-9]
22. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Bürgel N, Fromm M, Zeitz M, Fuss I, Strober W, Schulzke JD. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005; 129: 550-564 [PMID: 16083712 DOI: 10.1053/ j.gastro.2005.05.002]
23. Zeissig S, Bürgel N, Günzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut 2007; 56: 61-72 [PMID: 16822808 DOI: 10.1136/gut.2006.094375]
24. Amasheh M, Grotjohann I, Amasheh S, Fromm A, Söderholm JD, Zeitz M, Fromm M, Schulzke JD. Regulation of mucosal structure and barrier function in rat colon exposed to tumor necrosis factor alpha and interferon gamma in vitro: a novel model for studying the pathomechanisms of inflammatory bowel disease cytokines. Scand J Gastroenterol 2009; 44: 1226-1235 [PMID: 19658020 DOI: 10.1080/0036552090313 1973]
25. Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 2007; 17: 541-552 [PMID: 17296677 DOI: 10.1093/glycob/cwm014]
26. Matsumoto S, Nagaoka M, Hara T, Kimura-Takagi I, Mistuyama K, Ueyama S. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells. Clin Exp Immunol 2004; 136: 432-439 [PMID: 15147344 DOI: 10.1111/j.1365-2249.2004.02462.x]
27. Zhang XW, Liu Q, Thorlacius H. Inhibition of selectin function and leukocyte rolling protects against dextran sodium sulfate-induced murine colitis. Scand J Gastroenterol 2001; 36: 270-275 [PMID: 11305514]
28. Tanoue T, Nishitani Y, Kanazawa K, Hashimoto T, Mizuno M. In vitro model to estimate gut inflammation using cocultured Caco-2 and RAW264.7 cells. Biochem Biophys Res Commun 2008; 374: 565-569 [PMID: 18647595 DOI: 10.1016/ j.bbrc.2008.07.063]
29. Raghavendran HR, Srinivasan P, Rekha S. Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats. Int Immunopharmacol 2011; 11: 157-163 [PMID: 21084063 DOI: 10.1016/j.intimp.2010.11.002]
30. Choi JI, Raghavendran HR, Sung NY, Kim JH, Chun BS, Ahn DH, Choi HS, Kang KW, Lee JW. Effect of fucoidan on aspirin-induced stomach ulceration in rats. Chem Biol Interact 2010; 183: 249-254 [PMID: 19788892 DOI: 10.1016/ j.cbi.2009.09.015]
31. Willemsen LE, Hoetjes JP, van Deventer SJ, van Tol EA. Abrogation of IFN-gamma mediated epithelial barrier disruption by serine protease inhibition. Clin Exp Immunol 2005; 142: 275-284 [PMID: 16232214 DOI: 10.1111/ j.1365-2249.2005.02906.x]
32. Bruewer M, Luegering A, Kucharzik T, Parkos CA, Madara JL, Hopkins AM, Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-indepen-dent mechanisms. J Immunol 2003; 171: 6164-6172 [PMID: 14634132]
33. Li N, DeMarco VG, West CM, Neu J. Glutamine supports recovery from loss of transepithelial resistance and increase of permeability induced by media change in Caco-2 cells. J Nutr Biochem 2003; 14: 401-408 [PMID: 12915221 DOI: 10.1016/ S0955-2863(03)00071-8]
34. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 2011; 141: 769-776 [PMID: 21430248 DOI: 10.3945/jn.110.135657]
35. Amasheh M, Schlichter S, Amasheh S, Mankertz J, Zeitz M, Fromm M, Schulzke JD. Quercetin enhances epithelial barrier function and increases claudin-4 expression in Caco-2 cells. J Nutr 2008; 138: 1067-1073 [PMID: 18492835]
36. Amasheh M, Fromm A, Krug SM, Amasheh S, Andres S, Zeitz M, Fromm M, Schulzke JD. TNFalpha-induced and berberine-antagonized tight junction barrier impairment via tyrosine kinase, Akt and NFkappaB signaling. J Cell Sci 2010; 123: 4145-4155 [PMID: 21062898 DOI: 10.1242/jcs.070896]